How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Get the latest news on Recursion Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Recursion Pharmaceuticals performance ...
As of 10:35:56 a.m. EDT. Market Open.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Recursion Pharmaceuticals Inc insiders reported 6 transactions totaling $589,430.56. Activity included 2 tax payments, 2 stock sales, and 2 stock awards between July and August 2026. View more Major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results